The emerging roles of KPNA2 in cancer

被引:79
作者
Han, Yang [1 ,2 ]
Wang, Xin [1 ,2 ,3 ,4 ]
机构
[1] Shandong Univ, Shandong Prov Hosp, Dept Hematol, 324 Jingwu Rd, Jinan 250021, Shandong, Peoples R China
[2] Shandong Univ, Sch Med, Jinan 250012, Shandong, Peoples R China
[3] Shandong Prov Engn Res Ctr Lymphoma, Jinan 250021, Shandong, Peoples R China
[4] Key Lab Kidney Regenerat Shandong Prov, Jinan 250021, Shandong, Peoples R China
关键词
KPNA2; Tumor progress; Nucleocytoplasmic transport; Diagnostic biomarker; SQUAMOUS-CELL CARCINOMA; QUANTITATIVE PROTEOMICS REVEALS; EPITHELIAL OVARIAN-CANCER; KARYOPHERIN-ALPHA; POOR-PROGNOSIS; BREAST-CANCER; NUCLEOCYTOPLASMIC TRANSPORT; NUCLEAR TRANSLOCATION; UROTHELIAL CARCINOMA; SUBUNIT ALPHA-2;
D O I
10.1016/j.lfs.2019.117140
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Karyopherin alpha 2 (KPNA2, also known as importin alpha-1), a member of the nuclear transporter family, is involved in the nucleocytoplasmic transport pathway of a variety of tumor-associated proteins. Recent studies have found that KPNA2 is overexpressed in various cancers, which is associated with poor prognosis. In addition, it has been shown to promote tumor formation and progression by participating in cell differentiation, proliferation, apoptosis, immune response, and viral infection. It is indicated that KPNA2 also plays an important role in the diagnosis, treatment and prognosis of tumors. Herein, we provide an overview of the function and mechanism of KPNA2 in cancer and the prospects in the diagnosis and treatment of cancer. In the future, KPNA2 provides new ideas for the early diagnosis of malignant tumors, the development of molecularly targeted drugs, and prognosis evaluation.
引用
收藏
页数:9
相关论文
共 92 条
[1]   Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response [J].
Al-Kaabi, M. M. ;
Alshareeda, A. T. ;
Jerjees, D. A. ;
Muftah, A. A. ;
Green, A. R. ;
Alsubhi, N. H. ;
Nolan, C. C. ;
Chan, S. ;
Cornford, E. ;
Madhusudan, S. ;
Ellis, I. O. ;
Rakha, E. A. .
BRITISH JOURNAL OF CANCER, 2015, 112 (05) :901-911
[2]   KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer [J].
Alshareeda, A. T. ;
Negm, O. H. ;
Green, A. R. ;
Nolan, C. C. ;
Tighe, P. ;
Albarakati, N. ;
Sultana, R. ;
Madhusudan, S. ;
Ellis, I. O. ;
Rakha, E. A. .
BRITISH JOURNAL OF CANCER, 2015, 112 (12) :1929-1937
[3]   SUMOylation proteins in breast cancer [J].
Alshareeda, Alaa T. ;
Negm, Ola H. ;
Green, Andrew R. ;
Nolan, Christopher ;
Tighe, Paddy ;
Albarakati, Nada ;
Sultana, Rebeka ;
Madhusudan, Srinivasan ;
Ellis, Ian O. ;
Rakha, Emad A. .
BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (03) :519-530
[4]   Nuclear karyopherin-2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer [J].
Altan, Bolag ;
Yokobori, Takehiko ;
Mochiki, Erito ;
Ohno, Tetsuro ;
Ogata, Kyoichi ;
Ogawa, Atsushi ;
Yanai, Mitsuhiro ;
Kobayashi, Tsutomu ;
Luvsandagva, Baigalimaa ;
Asao, Takayuki ;
Kuwano, Hiroyuki .
CARCINOGENESIS, 2013, 34 (10) :2314-2321
[5]   mTORC1 alters the expression of glycolytic genes by regulating KPNA2 abundances [J].
Chen, Xianwei ;
Zhu, Yinghui ;
Wang, Zhaohui ;
Zhu, Huishan ;
Pan, Qingfei ;
Su, Siyuan ;
Dong, Yusheng ;
Li, Li ;
Zhang, Hongbing ;
Wu, Lin ;
Lou, Xiaomin ;
Liu, Siqi .
JOURNAL OF PROTEOMICS, 2016, 136 :13-24
[6]   Karyopherins and nuclear import [J].
Chook, YM ;
Blobel, G .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2001, 11 (06) :703-715
[7]   The functional role of the novel biomarker karyopherin α 2 (KPNA2) in cancer [J].
Christiansen, Anders ;
Dyrskjot, Lars .
CANCER LETTERS, 2013, 331 (01) :18-23
[8]   Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin α2 as a potential novel prognostic marker in breast cancer [J].
Dahl, Edgar ;
Kristiansen, Glen ;
Gottlob, Kathrin ;
Klaman, Irina ;
Ebner, Elke ;
Hinzmann, Bernd ;
Hermann, Klaus ;
Pilarsky, Christian ;
Duerst, Matthias ;
Klinkhammer-Schalke, Monika ;
Blaszyk, Hagen ;
Knuechel, Ruth ;
Hartmann, Arndt ;
Rosenthal, Andre ;
Wild, Peter J. .
CLINICAL CANCER RESEARCH, 2006, 12 (13) :3950-3960
[9]   KPNA2 protein expression in invasive breast carcinoma and matched peritumoral ductal carcinoma in situ [J].
Dankof, Anja ;
Fritzsche, Florian R. ;
Dahl, Edgar ;
Pahl, Stefan ;
Wild, Peter ;
Dietel, Manfred ;
Hartmann, Arndt ;
Kristiansen, Glen .
VIRCHOWS ARCHIV, 2007, 451 (05) :877-881
[10]   Nuclear Pore Complexes and Nucleocytoplasmic Transport: From Structure to Function to Disease [J].
Dickmanns, Achim ;
Kehlenbach, Ralph H. ;
Fahrenkrog, Birthe .
INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 320, 2015, 320 :171-233